THE DEAL, AT A GLANCE
From the announcementVedanta Biosciences
01Who is involvedBacked by AMR Action Fund, BNP Paribas Asset Management Alts, BARDAFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedVedanta Biosciences raised $60M Series B, announced 2026-08-06From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersVedanta Biosciences' $60M Series B positions the company as a mid-market FinTech financing event, with round size above the median at the 58th percentile of tracked…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Vedanta Biosciences · Financing Record
Explore source-linked visual explanations for Vedanta Biosciences. Unsupported claims are withheld while source review continues.
Record 9782 · Recorded date: 2026-08-06
Explore company records →